Form 4: BioMarin EVP Cristin Hubbard Reports Stock Disposal to Cover Tax Obligations
SEC Form 4 Filing
Cristin Hubbard, EVP and Chief Commercial Officer of BioMarin Pharmaceutical Inc., disposed of 2,155 shares of common stock on May 20, 2025, to satisfy tax withholding obligations.
Summary
- On May 20, 2025, Cristin Hubbard, the EVP and Chief Commercial Officer of BioMarin Pharmaceutical Inc., disposed of 2,155 shares of common stock.
- The transaction was executed at a price of $59.93 per share.
- This disposal was related to the satisfaction of tax withholding obligations.
- Following the transaction, Hubbard directly owns 30,545 shares of BioMarin common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment with shareholder interests.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine sale of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of stock disposal transaction |
| 05/22/2025 | Date of signature for the Form 4 filing |
Keywords
BioMarin Pharmaceutical, BMRN, Cristin Hubbard, Form 4, Stock Disposal, Tax Withholding, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.